Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2016-12, Vol.134 (23), p.1909-1911
Hauptverfasser:	Gordon, Lori A, Kumar, Parag, Brooks, Kristina M, Kellogg, Anela, McManus, Maryellen, Alfaro, Raul M, Nghiem, Khanh, George, Jomy M, Lozier, Jay, Penzak, Scott R, Hadigan, Colleen
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Antithrombins - administration & dosage Antithrombins - adverse effects Antithrombins - pharmacokinetics Blood Coagulation - drug effects Cobicistat - administration & dosage Cobicistat - adverse effects Cytochrome P-450 CYP3A Inhibitors - administration & dosage Cytochrome P-450 CYP3A Inhibitors - adverse effects Dabigatran - administration & dosage Dabigatran - adverse effects Dabigatran - pharmacokinetics Drug Interactions Healthy Volunteers Humans Thrombin Time
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!